Release 4B
TerminologyThis page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B R4
| Pharmacy Work Group | Maturity Level: 1 | Draft | Use Context: Not Intended for Production use |
This is a value set defined by the FHIR project.
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/reason-medication-status-codes |
| Version: | 4.3.0 |
| Name: | SNOMEDCTDrugTherapyStatusCodes |
| Title: | SNOMED CT Drug Therapy Status codes |
| Definition: | This value set includes some taken and not taken reason codes from SNOMED CT - provided as an exemplar |
| Committee: | Pharmacy Work Group |
| OID: | 2.16.840.1.113883.4.642.3.369 (for OID based terminology systems) |
| Copyright: | This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement |
| Source Resource | XML / JSON |
This value set is used in the following places:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 266710000 (Drugs not taken/completed)http://snomed.info/sct where concept is-a 410684002 (Drug therapy status)
This expansion generated 28 May 2022
This value set contains 194 concepts
Expansion based on SNOMED CT International edition 31-Jul 2020
All codes in this table are from the system http://snomed.info/sct
| Code | Display |
| 266710000 | Drugs not taken/completed |
| 182862001 | Drug not taken - dislike taste |
| 182863006 | Drug not taken - dislike form |
| 182864000 | Drug not taken - side-effects |
| 182865004 | Drug not taken - inconvenient |
| 182868002 | Treatment stopped - alternative therapy undertaken |
| 182869005 | Drug not taken - patient lost tablets |
| 182870006 | Drug discontinued - reason unknown |
| 182871005 | Drug discontinued - patient fear/risk |
| 182872003 | Drug discontinued - too expensive |
| 182873008 | Drug treatment stopped - patient ran out of tablets |
| 182874002 | Treatment stopped - patient unable to concentrate |
| 266711001 | Drug not taken - problem swallowing |
| 275929009 | Tablets too large to swallow |
| 410684002 | Drug therapy status |
| 134390006 | Angiotensin converting enzyme inhibitor not indicated |
| 134397009 | Angiotensin converting enzyme inhibitor declined |
| 135794007 | Drug indicated |
| 135795008 | Nitrate indicated |
| 135796009 | Calcium channel blocker indicated |
| 135798005 | Diuretic indicated |
| 135799002 | Angiotensin converting enzyme inhibitor indicated |
| 135800003 | Aspirin indicated |
| 135801004 | Beta blocker indicated |
| 135803001 | Warfarin indicated |
| 161646004 | H/O: high risk medication |
| 161647008 | H/O: anticoagulant therapy |
| 161648003 | H/O: steroid therapy |
| 161649006 | H/O: insulin therapy |
| 161650006 | H/O: anticonvulsant therapy |
| 161652003 | H/O: hormone replacement (HRT) |
| 161653008 | H/O: chemotherapy |
| 170622002 | Oral steroids started |
| 170624001 | Oral steroids stopped |
| 170688000 | Lithium stopped |
| 170689008 | Injectable phenothiazine stopped |
| 170821007 | B12 injections started |
| 170826002 | B12 injections stopped |
| 170919001 | Warfarin therapy stopped |
| 170954008 | HRT contraindicated |
| 170955009 | HRT started |
| 170958006 | HRT stopped |
| 182834008 | Drug course completed |
| 182840001 | Drug treatment stopped - medical advice |
| 182841002 | Dr stopped drugs - ineffective |
| 182842009 | Doctor stopped drugs - side effect |
| 182843004 | Dr stopped drugs -inconvenient |
| 182844005 | Doctor stopped drugs - patient dislikes |
| 182845006 | Doctor stopped drugs - avoid interaction |
| 182846007 | Doctor stopped drugs - medical aim achieved |
| 274512008 | Drug therapy discontinued |
| 309841001 | Thyroxine treatment stopped |
| 312451002 | Aspirin prophylaxis contra-indicated |
| 315023008 | Aspirin prophylaxis refused |
| 315062004 | Beta blocker contraindicated |
| 315364008 | Angiotensin converting enzyme inhibitors contraindicated |
| 390914001 | Thrombolytic therapy refused |
| 391158008 | Antibiotic prophylaxis recommended |
| 391159000 | Antibiotic prophylaxis not recommended |
| 394888000 | Hormone replacement therapy requested |
| 394987009 | Angiotensin II receptor antagonists contraindicated |
| 395006008 | Medication stopped - interaction |
| 395007004 | Medication stopped - ineffective |
| 395008009 | Medication stopped - contra-indication |
| 395009001 | Medication stopped - side effect |
| 401084003 | Angiotensin II receptor antagonist declined |
| 401244004 | H/O: prolonged corticosteroid therapy |
| 407572003 | Angiotensin II receptor antagonist not indicated |
| 408339001 | Thrombolysis therapy not indicated |
| 408354007 | Drug treatment still needed |
| 408355008 | Drug treatment no longer needed |
| 412782003 | Inappropriate medication stopped |
| 413555000 | Antibiotic prophylaxis indicated |
| 413558003 | Anticoagulation contraindicated |
| 413559006 | Anticoagulation declined |
| 413560001 | Anticoagulation not indicated |
| 416404000 | Angiotensin converting enzyme inhibitor target dose not achieved |
| 417576009 | Deferred antibiotic therapy |
| 430279008 | Drug treatment stopped at end of clinical trial (situation) |
| 438553004 | History of drug therapy (situation) |
| 439631004 | History of statin therapy (situation) |
| 440935004 | History of beta adrenergic receptor blocking agent therapy (situation) |
| 440991005 | History of nitrate therapy (situation) |
| 441195008 | History of angiotensin converting enzyme inhibitor therapy (situation) |
| 441196009 | History of angiotensin II receptor antagonist therapy (situation) |
| 441899004 | History of therapy with ototoxic medication |
| 473151000 | History of tuberculosis drug therapy (situation) |
| 698428006 | Angiotensin II receptor antagonist indicated |
| 698449007 | Antibiotic therapy indicated |
| 698459008 | Antidepressant drug treatment stopped |
| 698460003 | Antiviral therapy declined |
| 698468005 | Bisoprolol contraindicated (situation) |
| 698758004 | Nebivolol therapy refused |
| 699008007 | History of fenfluramine therapy |
| 699137009 | Carvedilol therapy declined |
| 700110004 | Bisphosphonate prophylaxis suspended |
| 700384008 | Antibiotic prophylaxis not indicated |
| 702542006 | Incretin mimetic therapy started (situation) |
| 703989007 | Teriparatide therapy declined (situation) |
| 703991004 | Raloxifene therapy declined |
| 703996009 | Teriparatide not indicated (situation) |
| 703997000 | Teriparatide contraindicated |
| 703999002 | Raloxifene contraindicated |
| 704000000 | Raloxifene not indicated |
| 704033005 | Phosphodiesterase 5 inhibitor not indicated (situation) |
| 704047009 | Phosphodiesterase 5 inhibitor declined (situation) |
| 707298000 | Phosphodiesterase-5 inhibitor contraindicated (situation) |
| 708000007 | Insulin treatment stopped (situation) |
| 710159007 | Long-term current use of immunosuppressive drug (situation) |
| 710814002 | Long-term current use of drug therapy |
| 710815001 | Long-term current use of insulin |
| 710816000 | Long-term current use of steroid |
| 710817009 | Long-term current use of inhaled steroid (situation) |
| 711149003 | Long-term current use of antibiotic (situation) |
| 711150003 | Long-term current use of anticoagulant (situation) |
| 711370000 | Oral steroids used since last encounter (situation) |
| 711436000 | Inhaled steroids used daily (situation) |
| 712985002 | Chemotherapy not done |
| 720971004 | Insulin declined (situation) |
| 721872002 | Antifungal therapy indicated (situation) |
| 722480002 | Chemotherapy started (situation) |
| 736004008 | Nebivolol contraindicated (situation) |
| 736006005 | Carvedilol contraindicated (situation) |
| 736799004 | Beta blocker target dose not achieved (situation) |
| 763323007 | Hormone replacement therapy refused |
| 764639002 | Antidepressant drug treatment started (situation) |
| 787928003 | Coagulation factor Xa inhibitor prophylaxis indicated |
| 787930001 | Direct thrombin inhibitor prophylaxis indicated |
| 840596001 | H/O: platelet aggregation inhibitor therapy |
| 840597005 | Long term dual platelet aggregation inhibitor therapy indicated |
| 840598000 | Platelet aggregation inhibitor therapy contraindicated (situation) |
| 7611000175100 | Dipyridamole contraindicated (situation) |
| 21651000175103 | Antibiotic prophylaxis declined (situation) |
| 21681000175107 | Antihypertensive therapy declined (situation) |
| 53081000119101 | Long-term current use of testosterone replacement therapy (situation) |
| 61251000119108 | Long-term current use of tacrolimus (situation) |
| 61261000119105 | Long-term current use of sirolimus (situation) |
| 69521000119101 | Long-term current use of thyroid hormone replacement therapy (situation) |
| 98001000119105 | Long-term current use of anticonvulsant (situation) |
| 106511000119106 | Long-term current use of mycophenolate |
| 106521000119104 | Long-term current use of cyclophosphamide |
| 106571000119103 | Long-term current use of sulfasalazine (situation) |
| 106581000119100 | Long-term current use of cyclosporine (situation) |
| 106631000119102 | Long-term current use of infliximab (situation) |
| 106691000119103 | Long-term current use of etanercept (situation) |
| 106701000119103 | Long-term current use of leflunomide (situation) |
| 113481000119108 | Long-term current use of tamoxifen (situation) |
| 113521000119108 | Long term current use of adalimumab therapy |
| 113531000119106 | Long term current use of abatacept (situation) |
| 113541000119102 | Long-term current use of rituximab (situation) |
| 117431000119101 | Long term current use of drug therapy for attention deficit hyperactivity disorder (situation) |
| 118901000119102 | Long-term current use of erythropoiesis stimulating therapy (situation) |
| 118911000119104 | Long-term current use of lenalidomide (situation) |
| 118921000119106 | Long-term current use of clozapine (situation) |
| 118931000119109 | Long-term current use of intravenous immune globulin (situation) |
| 122621000119109 | Prophylactic anticoagulation given (situation) |
| 123971000119106 | Long-term current use of acitretin (situation) |
| 123981000119109 | Long-term current use of isotretinoin (situation) |
| 126951000119109 | Long-term current use of lithium (situation) |
| 127721000119100 | Long-term current use of testosterone cypionate (situation) |
| 130721000119103 | Long-term current use of golimumab (situation) |
| 131531000119103 | Long-term current use of aspirin (situation) |
| 133621000119103 | Long term current use of non-steroidal anti-inflammatory drug |
| 134651000119108 | History of estrogen therapy |
| 134671000119104 | History of systemic steroid therapy (situation) |
| 139181000119106 | Long-term current use of amiodarone (situation) |
| 140301000119107 | Long-term current use of hydroxychloroquine |
| 140561000119102 | Long-term current use of azathioprine |
| 150881000119107 | Long-term current use of postmenopausal hormone replacement therapy (situation) |
| 328941000119101 | Long-term current use of bisphosphonates (situation) |
| 329061000119105 | Long-term current use of belimumab (situation) |
| 329071000119104 | Long-term current use of tocilizumab (situation) |
| 347841000119106 | Long-term current use of cannabis (situation) |
| 11012701000119107 | Long-term current use of antibiotics for prevention of recurrent infection (situation) |
| 11012741000119109 | Long-term current use of certolizumab pegol (situation) |
| 12384021000119106 | Long-term current use of mercaptopurine (situation) |
| 15625371000119108 | Long-term current use of ustekinumab (situation) |
| 15625411000119109 | Long-term current use of apremilast (situation) |
| 15625451000119105 | Long-term current use of tofacitinib (situation) |
| 15929341000119102 | Long-term current use of antipsychotic medication (situation) |
| 15929381000119107 | Long-term current use of anxiolytic medication (situation) |
| 15929421000119103 | Long-term current use of antiviral agent (situation) |
| 15929461000119108 | Long-term current use of leuprorelin (situation) |
| 15929581000119100 | Long-term current use of antidepressant medication (situation) |
| 16234971000119108 | Long-term current use of diuretic (situation) |
| 16526761000119100 | Long-term current use of secukinumab (situation) |
| 16659291000119100 | Long-term current use of levothyroxine (situation) |
| 16755631000119109 | Long-term current use of natalizumab (situation) |
| 16755671000119107 | Long-term current use of mesalamine |
| 16772161000119102 | Long-term current use of vedolizumab (situation) |
| 16772201000119107 | Long-term current use of everolimus (situation) |
| 16863441000119108 | Long-term current use of stimulant |
| 16863481000119103 | Long-term current use of benzodiazepine (situation) |
| 70732231000132107 | Duplicate drug therapy stopped |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR ®© HL7.org 2011+. FHIR Release 4B (v4.3.0) hl7.fhir.r4b.core#4.3.0 generated on Sat, May 28, 2022 12:51+1000.
Links: Search |
Version History |
Table of Contents |
QA Page |
Compare to R4 |
|
Propose a change